🇺🇸 LQDA — Liquidia Corporation

Salud Compra
← Volver

Precio actual

42,20 USD

Máx. histórico

91,03

85 días

Caída desde máximo

-53,64%

Rango 52 semanas

22,31 – 93,61

Variación hoy

+0,84%

Cierre anterior

41,85

Rango de hoy

41,58 – 43,37

Volumen hoy

2.182.208

Peor caída histórica

-93,87%

09/10/2018 → 04/08/2021

Recuperado en 1623 días

Volatilidad anualizada ⓘ

87,49%

Información
Nombre completo
Liquidia Corporation
Divisa
USD
Mercado
NasdaqCM
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
216
PER ⓘ
30,36 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
54,38 USD (puede no estar actualizado)
Primera cotización
26/07/2018
Precio actualizado
hace 20 horas
Sobre la empresa

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also provides Remodulin, a treprostinil injection administered through continuous intravenous and subcutaneous infusion; and develops L606, an investigational liposomal formulation of treprostinil which is in phase III clinical trial for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). In addition, the company offers PRINT technology which allows to engineer and manufacture uniform drug particles with precise control over the size, three-dimensional geometric shape, and chemical composition of the particles. It has a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD; Vectura; The University of North Carolina at Chapel Hill; GlaxoSmithKline; Alcon Inc; and promotion Agreement with Sandoz. Liquidia Corporation was founded in 2004 and is based in Morrisville, North Carolina.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
19/12/2023 7,70 8,02 7,62 7,89 +5,62% 5,19% 1.351.900
18/12/2023 7,51 7,59 7,34 7,47 +0,27% 3,33% 907.800
15/12/2023 7,48 7,54 7,20 7,45 +2,19% 4,55% 1.278.100
14/12/2023 7,20 7,31 7,03 7,29 +1,96% 3,89% 827.100
13/12/2023 7,22 7,25 6,90 7,15 -1,24% 4,85% 924.800
12/12/2023 7,11 7,58 6,86 7,24 +1,12% 10,13% 1.372.400
11/12/2023 7,23 7,23 6,97 7,16 -0,97% 3,60% 474.400
08/12/2023 7,20 7,35 7,11 7,23 +0,42% 3,33% 296.200
07/12/2023 7,14 7,39 7,09 7,20 +0,28% 4,20% 464.800
06/12/2023 6,92 7,41 6,85 7,18 +4,06% 8,09% 593.500
05/12/2023 7,39 7,40 6,83 6,90 -7,01% 7,71% 730.700
04/12/2023 7,28 7,78 7,07 7,42 +2,06% 9,75% 1.792.800
01/12/2023 7,16 7,31 6,82 7,27 +1,54% 6,84% 731.200
30/11/2023 7,21 7,41 7,09 7,16 +0,28% 4,44% 602.400
29/11/2023 7,08 7,27 7,02 7,14 +0,99% 3,53% 555.800
28/11/2023 6,92 7,14 6,85 7,07 +2,91% 4,19% 1.183.100
27/11/2023 6,85 7,09 6,73 6,87 +0,29% 5,26% 554.400
24/11/2023 6,72 6,89 6,69 6,85 +1,93% 2,98% 155.300
22/11/2023 6,68 6,75 6,60 6,72 +1,82% 2,25% 267.500
21/11/2023 6,45 6,66 6,42 6,60 +1,54% 3,72% 337.700
20/11/2023 6,35 6,59 6,33 6,50 +2,69% 4,09% 456.600
17/11/2023 6,37 6,37 6,19 6,33 +0,32% 2,83% 418.600
16/11/2023 6,46 6,46 6,10 6,31 -1,87% 5,57% 400.000
15/11/2023 6,36 6,54 6,30 6,43 +0,78% 3,77% 397.500
14/11/2023 6,48 6,55 6,30 6,38 +0,79% 3,86% 386.100
13/11/2023 6,25 6,35 6,13 6,33 +0,96% 3,52% 300.900
10/11/2023 6,14 6,30 6,06 6,27 +2,28% 3,91% 318.500
09/11/2023 6,50 6,50 6,08 6,13 -5,69% 6,46% 487.500
08/11/2023 6,71 6,83 6,45 6,50 -4,41% 5,66% 286.500
07/11/2023 6,55 6,85 6,16 6,80 +3,66% 10,53% 562.900